DrugInformer Search

Cenestin Related Endometrial cancer

Official Government Database Reports0
Online Conversations2

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.

Tell us about your Experience with Cenestin

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Hysterectomy, Endometrial cancer

Posted By Debby in fdb.rxlist.com on August 10, 2014 @ 12:00 am

Had a complete hysterectomy in 2001. Dr. prescribed cenestin and I was on it for 7 years. Maybe it worked for hot flashes, etc. however, I wish I would have never heard of this drug because in 2008, w...

Druginformer Identified Side Effects: Night sweats, Hysterectomy, Ovarian cancer, Endometrial cancer, Weight increased

Posted By Anonymous in askapatient.com on January 18, 2010 @ 12:00 am

Side Effects: started cenestin after the hysterectomy in 2001. Kept asking the Dr. if it was safe. I had read that you should only take it short term. Still had night sweats and weight gain from it. ...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.